Granisetron versus ondansetron treatment for breakthrough postoperative nausea and vomiting after prophylactic ondansetron failure: A pilot study

Anesthesia and Analgesia

Volumn 104, Issue 6, 2007, Pages 1370-1373

  Candiotti, Keith A ^a   Nhuch, Fani ^a   Kamat, Aimee ^a   Deepika, Krisnaprasad ^a   Arheart, Kristopher L ^a   Birnbach, David J ^a   Lubarsky, David A ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FENTANYL; GLYCOPYRRONIUM BROMIDE; GRANISETRON; ISOFLURANE; MIDAZOLAM; NEOSTIGMINE; NITROUS OXIDE; ONDANSETRON; ROCURONIUM; SUXAMETHONIUM; THIOPENTAL; VECURONIUM;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG DOSE COMPARISON; DRUG TREATMENT FAILURE; FEMALE; GENERAL ANESTHESIA; HUMAN; MAJOR CLINICAL STUDY; PILOT STUDY; POSTOPERATIVE NAUSEA AND VOMITING; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; SURGICAL TECHNIQUE; TREATMENT RESPONSE;

ADULT; CROSS-OVER STUDIES; FEMALE; GRANISETRON; HUMANS; MIDDLE AGED; ONDANSETRON; PILOT PROJECTS; POSTOPERATIVE NAUSEA AND VOMITING; TIME FACTORS; TREATMENT FAILURE;

EID: 34249021047     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ane.0000261474.85547.8b     Document Type: Article

References (8)

1. Leeser J, Lip H. Prevention of postoperative nausea and vomiting using ondansetron, a new selective 5-HT3 receptor antagonist. Anesth Analg 1991;72:751-5.
2. Kovac AL, O'Connor TA, Pearman MH, et al. Efficacy of repeat intravenous dosing of ondansetron in controlling postoperative nausea and vomiting: a randomized, double-blind, placebo-controlled multicenter trial. J Clin Anesth 1999;11:453-9.
3. de Wit R, de Boer AC, vd Linden GH, et al. Effective cross-over to granisetron after failure to ondansetron, a randomized double blind study in patients failing ondansetron plus dexamethasone during the first 24 hours following highly emetogenic chemotherapy. Br J Cancer 2001;85:1099-101.
4. Kaiser R, Sezer O, Papies A, et al. Patient-tailored antiemetic treatment with 5-hydroxytryptamine type 3 receptor antagonists according to cytochrome P-450 2D6 genotypes. J Clin Oncol 2002;20:2805-11.
5. Candiotti KA, Birnbach DJ, Lubarsky DA, et al. The impact of pharmacogenomics on postoperative nausea and vomiting: do CYP2D6 allele copy number and polymorphisms affect the success or failure of ondansetron prophylaxis? Anesthesiology 2005;102:543-9.
6. Watcha MF, White PF. Postoperative nausea and vomiting. Its etiology, treatment and prevention. Anesthesiology 1992;77:162-84.
7. Taylor AM, Rosen M, Diemunsch PA, et al. A double-blind, parallel-group, placebo-controlled, dose-ranging, multicenter study of intravenous granisetron in the treatment of postoperative nausea and vomiting in patients undergoing surgery with general anesthesia. J Clin Anesth 1997;9:658-63.
8. Cohen J. Statistical power for the behavorial sciences. Hillsdale, NJ: Erlbaum, 1988.